1984 BSc Applied Biology, Brunel University, London
1985 MSc Nutrition (Distinction), King’s College, University of London
1988 PhD Nutrition, King’s College, University of London
2009-present Manager, Scottish Primary Care Research Network
2008-2009 Research Manager, Scottish School of Primary Care
2003-2008 NHS Programmes and Primary Care Manager, Chief Scientist Office
2002-2003 Public Health Scientist, Dept Public Health, NHS Fife
1998-2002 Senior Researcher and Acting Director, Centre for Health and Social Research, NHS Fife
1996-1997 Research Scientist, Scottish Liver Transplant Unit, Edinburgh Royal Infirmary
1992-1995 Research Scientist, Dept Infant Nutrition, MRC Dunn Nutrition Unit, Cambridge
1989-1992 Postdoctoral Fellow, Dep Paediatrics, University of Calgary, Canada
PhD Thesis title: The influence of the omega-3 fatty acids in fish oil on inflammation and immune function.
Canadian Cystic Fibrosis Foundation Research Grant: Postprandial hyperglycaemia in patients with cystic fibrosis.
MRC Dunn Nutrition Unit: A longitudinal study of growth and development of 200 children
Scottish Liver Transplant Unit: Energy expenditure and food preference in patients with liver disease pre and post transplant
CHSR: Health and Social Research projects
- Mrs. Amy L Howie
1. Sanders TAB, Hinds A, Periera CC. (1989) J Int Med 225, 99-104.
Influence of n-e fatty acids on blood lipids in normal subjects.
2. Hinds A. (1991) Can Med Assoc J 145, 35. Nutrients as modulators of immune function.
3. Hinds A, Sheehan AG, Machida H, Parsons HG. (1991) Diabetes Res 18, 69-78. Postprandial hyperglycaemia and pancreatic function in cystic fibrosis patients.
4. Sanders TAB & Hinds A. (1992) Br J Nutr 68, 163-173. The influence of a fish oil high in docosahexanoic acid on plasma lipoprotein and vitamin E concentrations and haemostatic function in healthy male volunteers.
5. Hinds A. & Sanders TAB. (1993) Br J Nutr 69, 143-149. Influence of acute and chronic administration of eicosapentaenoic (20:5 n-3) and docosahexanoic (22:3 n-6) acids on lymphocyte composition and cell-mediated immunity in the mouse.
6. Hinds A, Sheehan AG, Parsons HG. (1995) Metabolism 44, 13-18. Tolbutamide causes a modest increase in insulin secretion on cystic fibrosis patients with impaired glucose tolerance.
7. Davies PSW, Wells JCK, Hinds A, Day JME, Laidlaw A. (1997) Euro. J. Clin. Nutr. 51, 249-252. Total energy expenditure in 9 and 12 month old infants.
8. Wells J, Hinds A, Davies PSW. (1997) Arch Dis Child 76, 490-494. Free-living energy expenditure and behaviour in late infancy.
9. Richardson RA, Davidson HIM, Hinds A, McGilchrist A, Garden OJ. (1999) Am J Clin Nutr69, 331-337. The influence of the metabolic sequale of liver cirrhosis on nutritional intake.
10. Hinds A, Sinclair A, Park J, Suttie A, Paterson H, Macdonald M. (2003) Br J Ophthalmol 87, 1391-1396. The impact of an interdisciplinary low vision service on the quality of life of low vision patients.
11. Wallace E, Hinds A, Campbell H, Horobin J, Cetnarskyj R, Wilson J, Porteous M. (2004) Br J Cancer 18;91(8):1575-9. A cross-sectional survey to estimate the prevalence of family history of colorectal, breast and ovarian cancer in a Scottish general practice population.
12. Hinds A, Cameron JC. (2004) Commun Dis Public Health 7(4):278-82. Acceptability of universal hepatitis B vaccination among school pupils and parents.
13. Sinclair A, Hinds A, Sanders R. (2004) Ophthalmic Physiol Opt. 24 (4):313-8. Ten years of glaucoma blindness in Fife 1990-99 and the implications for ophthalmology, optometry and rehabilitation services
14. Hinds A. (2008) Inform Prim Care16(4):271-5. Data confidentiality and data handling in research: a workshop report
15. Sullivan FM, Hinds A, Pitkethly M, Treweek S, Wilson P, Wyke S (2014) J Eur Prim Care 20 (4): 337-42. Primary care research network progress in Scotland.